These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 7687333)

  • 1. Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone.
    Gouarderes C; Jhamandas K; Cridland R; Cros J; Quirion R; Zajac JM
    Neuroscience; 1993 Jun; 54(3):799-807. PubMed ID: 7687333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for delta-opioid receptor subtypes in the rat.
    Tiseo PJ; Yaksh TL
    Eur J Pharmacol; 1993 May; 236(1):89-96. PubMed ID: 8391455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord.
    Mauborgne A; Lutz O; Legrand JC; Hamon M; Cesselin F
    J Neurochem; 1987 Feb; 48(2):529-37. PubMed ID: 2432185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of mu opioid binding sites in rat spinal cord by chronic intrathecal infusion of morphine and naloxone: a quantitative autoradiography approach.
    Gouarderes C; Jhamandas K; Zajac JM; Beaudet A; Cros J; Quirion R
    Prog Clin Biol Res; 1990; 328():175-8. PubMed ID: 2154775
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release.
    Kondo I; Marvizon JC; Song B; Salgado F; Codeluppi S; Hua XY; Yaksh TL
    J Neurosci; 2005 Apr; 25(14):3651-60. PubMed ID: 15814796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding in vivo of selective mu and delta opioid agonists: localization by autoradiography.
    Mokhtari M; Tafani JA; Zajac JM
    Neuropeptides; 1993 Sep; 25(3):183-91. PubMed ID: 8247256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal development of multiple opioid receptors in the spinal cord and development of spinal morphine analgesia.
    Rahman W; Dashwood MR; Fitzgerald M; Aynsley-Green A; Dickenson AH
    Brain Res Dev Brain Res; 1998 Jun; 108(1-2):239-54. PubMed ID: 9693800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
    Wong CS; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):317-26. PubMed ID: 1320689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at delta opioid receptors.
    Collin E; Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F
    Neuropeptides; 1994 Jul; 27(1):75-83. PubMed ID: 7969822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
    Narita M; Mizoguchi H; Kampine JP; Tseng LF
    Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of spinal opioid receptors in the antinociceptive interactions between intrathecal morphine and bupivacaine.
    Tejwani GA; Rattan AK; McDonald JS
    Anesth Analg; 1992 May; 74(5):726-34. PubMed ID: 1314527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High resolution radioautographic localization of [125I]FK-33-824-labelled mu opioid receptors in the spinal cord of normal and deafferented rats.
    Gouardères C; Beaudet A; Zajac JM; Cros J; Quirion R
    Neuroscience; 1991; 43(1):197-209. PubMed ID: 1717884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C; Jhamandas K; Sutak M; Zajac JM
    Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of calcitonin gene related peptide and its receptor binding sites during the development of tolerance to mu and delta opioids.
    Ménard DP; van Rossum D; Kar S; Quirion R
    Can J Physiol Pharmacol; 1995 Jul; 73(7):1089-95. PubMed ID: 8846407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors.
    Riba P; Ben Y; Smith AP; Furst S; Lee NM
    J Pharmacol Exp Ther; 2002 Jan; 300(1):265-72. PubMed ID: 11752125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.